Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/5/25 21:04 | 2/5/25 | SPRO | Health | Drug | Pharmaceutical Preparations | Keutzer Timothy | MA | O | COO | 3 | S | -89 | 0.9943 | 0 | -90 | 741 | D | |||||||||||||||
2/5/25 20:52 | 2/5/25 | SPRO | Health | Drug | Pharmaceutical Preparations | Rajavelu Esther | MA | O | CFO,CBO | 2 | S.m | -69 | 1.13 | 0 | -61 | 725 | D | |||||||||||||||
2/5/25 20:31 | 2/5/25 | SPRO | Health | Drug | Pharmaceutical Preparations | Shukla Sath | MA | O | CEO,P | 4 | S.m | -275 | 1.03 | 0 | -267 | 1,737 | D | |||||||||||||||
2/5/25 20:30 | 2/5/25 | SPRO | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | D | 3 | S | -149 | 1.08 | 0 | -139 | 759 | D | ||||||||||||||||
2/5/24 20:48 | 2/2/24 | SPRO | Health | Drug | Pharmaceutical Preparations | Joseph Tamara L | MA | O | GC | 1 | S | -42 | 1.37 | 0 | -31 | 532 | D | |||||||||||||||
2/5/24 20:45 | 2/2/24 | SPRO | Health | Drug | Pharmaceutical Preparations | Hamed Kamal | MA | O | Chief Me | 1 | S | -38 | 1.37 | 0 | -28 | 788 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |